Gilad Oren bought APRE

December 10, 2025 · Form 4 insider transaction

Gilad Oren bought 21,459 shares of Aprea Therapeutics, Inc. at $1.17 per share, a transaction worth $25.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
21,459
Price
$1.17
Total value
$25.0K
InsiderGilad Oren
Role
SecurityPre-Funded Warrant
Transaction codeP: Open-market purchase
Transaction dateDecember 10, 2025
Filing dateDecember 11, 2025
Shares owned after21,459
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

On December 8, 2025, the Issuer entered into a securities purchase agreement with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement which closed on December 10, 2025 pre-funded warrants ("Pre-Funded Warrants") to purchase an aggregate of 21,459 shares of the Issuer's common stock ("Shares") at a purchase price of $1.165 per Pre-Funded Warrant. The Reporting Person also received accompanying common warrants ("Common Warrants") to purchase up to an aggregate of 21,459 Shares.; The Pre-Funded Warrants are immediately exercisable at any time after the date of issuance. Pursuant to the terms of the Pre-Funded Warrants, the Pre-Funded Warrants cannot be exercised to the extent that, upon giving effect to or immediately prior to such exercise, would cause either (i) the aggregate number of shares of Common Stock beneficially owned by such holder (together with its affiliates) would exceed 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise or (ii) the combined voting power of the Issuer's securities beneficially owned by such holder (together with its affiliates) would exceed 9.99% of the combined voting power of all of the Issuer's securities outstanding immediately after giving effect to the exercise (the "Beneficial Ownership Limitation")

View the original Form 4 on SEC EDGAR